Regado Biosciences
Regado Biosciences develops antithrombotic drug systems for acute and sub-acute cardiovascular and other indications.
Business Model:
Revenue: $0
Employees: 11-50
Rankings
Industries / Tags:
Detailed Regado Biosciences Information
Geographic Data
Address:
City: Durham
State: North Carolina
Zip:
Country: United States
Financial Info
Stage:
post ipo equity
Raised Last:
$20M
Raised Total:$154M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Regado Biosciences is a biopharmaceutical company, engages in the discovery and development of aptamer-based antidote-controlled therapeutics. It provides REG1 that is used in patients suffering from acute coronary syndrome who undergo coronary revascularization procedures, which include coronary artery bypass grafting and percutaneous coronary intervention. It was founded in 2001 and headquartered in Durham, North Carolina.
Contact Phone:
Contact Email:
Regado Biosciences went public on 8/22/2013 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
8/22/2013
Ticker Symbol:
RGDO
IPO Price:
$4/share
Amount Raised:
$43M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
